在一项新的研究中,通过分析2013~2016年埃博拉病毒爆发的一名存活者的血液,研究人员发现首个天然的人抗体能够中和所有三种主要的致病性埃博拉病毒,并且保护动物免受它们的感染。这些发现可能导致人们开发出首个广泛有效的埃博拉病毒药物和疫苗。相关研究结果发表在Cell期刊上,论文标题为“Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses”。 In a new study, analyzing the blood from a survivor of the Ebola outbreak in 2013-2016, the researchers found that the first natural human antibody was able to neutralize all three major pathogenic Ebola Viruses, and protect animals from their infection. These findings may lead to the first widely available Ebola virus drug and vaccine. Relevant findings published in the Cell journal titled “Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses.”